Skip to search formSkip to main contentSkip to account menu

Boostrix

National Institutes of Health

Related topics

Related topics

8 relations

Broader (8)

Bordetella pertussis filamentous hemagglutinin vaccine, inactivatedBordetella pertussis pertactin vaccine, inactivatedBordetella pertussis toxoid vaccine, inactivatedDiphtheria-Tetanus-(whole-cell) Pertussis Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
[Immunogenicity of sabin inactivated poliovirus vaccine induced by diphtheria-tetanus-acellular pertussis and Sabin inactivated poliovirus combined vaccine].
  • Yan MaMin Qin Ming Sun
  • Zhonghua shi yan he lin chuang bing du xue za zhi…
  • 2011
  • Corpus ID: 1602266
OBJECTIVE In order to search the preparation process and optimazing dosage ratio of adsorbed diphtheria-tetanus-acellular… 
2010
2010
Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™)
Pertussis continues to circulate in Chinese communities and older children, adolescents and adults are sources of infection for… 
2009
2009
FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine.
  • MMWR. Morbidity and mortality weekly report
  • 2009
  • Corpus ID: 30102812
On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)